- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02290015
Acupuncture as a Treatment for Tinnitus
November 8, 2014 updated by: Maura Regina Laureano, Federal University of São Paulo
Effectiveness of Acupuncture as a Treatment for Tinnitus: a Randomized Controlled Trial Using 99mTc-ECD SPECT
This trial was a randomized, single-blinded, sham-controlled study, in which the patients were blinded to treatment assignment.
First, all candidates underwent audiological testing of hearing thresholds, tympanometry and stapedius reflex tests.
The patients who were selected for the study were interviewed to assess and evaluate their condition and then underwent a detailed physical examination that included a complete otorhinolaryngologic examination and a complete blood test.
Then, the subjects were randomized to undergo true or sham ACP.
Seven days before (baseline) and seven days after twelve acupuncture (ACP) sessions (up to six weeks), which were performed twice a week, all participants underwent 99mTc-ECD SPECT scanning and completed the Portuguese version of the Tinnitus Handicap Inventory (THI), the Visual Analogue Scale (VAS), Hamilton Anxiety Scale (HAS) and the Beck Depression Inventory (BDI).
The purpose of this study was to integrate the neuroscience research findings with the clinical research on tinnitus.
Thus, a randomized, single-blinded, placebo-controlled trial was implemented to investigate the effect of ACP as a treatment for tinnitus using ethylcysteine dimer single-photon emission computer tomography (99mTc-ECD SPECT).
Study Overview
Detailed Description
Acupuncture (ACP) is frequently used to treat tinnitus, the condition defined as the perception of sound in the absence of an external auditory stimulus.
However, no information is available regarding the consequences of ACP on the neural architecture and functionality of the brain in tinnitus patients.
The aim of this study was to investigate changes in brain activity using ethylcysteine dimer single-photon emission computer tomography (99mTc-ECD SPECT) in patients with tinnitus and normal hearing who underwent ACP treatment.
Methods and Findings: This was a randomized, single-blinded, sham-controlled study.
The participants were adults (18-60 years old) with either normal hearing or chronic, idiopathic and continuous (+ 3 months) tinnitus.
Fifty-seven (57) subjects were randomized to receive true (n=30) or sham (n=27) ACP, and 99mTc-ECD SPECT exams were performed seven days before (baseline) and seven days after twelve ACP sessions (up to six weeks), which were performed twice a week.
Secondary outcomes included changes in the Tinnitus Handicap Inventory (THI), the Visual Analog Scale (VAS), the Hamilton Anxiety Scale (HAS) and the Beck Depression Inventory (BDI).
Data regarding imaging outcomes were analyzed with Statistical Parametric Mapping (SPM8) software using a factorial design.
For secondary outcomes, regression models were built considering two different analytical paradigms: intention-to-treat (ITT; where multiple imputations were conducted due to loss to follow-up) and complete cases.
No significant differences in brain perfusion were observed between patients who underwent true versus sham ACP treatment.
However, a significant improvement in THI scores at the end of true ACP treatment was observed for all domains (all p < 0.001), with the exception of the catastrophic field.
For the other outcome measurements (VAS, BDI and HAS), no significant differences were observed between groups.
The small sample size represents a potential limitation of this study.
Conclusions: These findings suggest that ACP may improve the impact of tinnitus on daily life, although additional studies are needed to verify the consequences of ACP on the neural architecture and functionality of the brain in tinnitus patients.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patients who met all the following conditions were considered for inclusion:
- 18 to 60 years of age
- Existence of typical conditions of subjective and continuous tinnitus, either unilateral or bilateral, for more than three months
- Normal hearing sensitivity in the conventional audiometric range (up to 25 dB from 250 to 8000 Hz) bilaterally and normal immittance measures (type A curve) in both ears
Exclusion Criteria:
The exclusion criteria were as follows:
- Objective, acute or intermittent tinnitus
- History of Ménière's disease
- Tinnitus induced by cerebellopontine angle tumors, cardiovascular disease, or a serious medical or mental illness
- History of central nervous system disease
- Current pregnancy or breast-feeding
- Patients with a lack of willingness or availability to cooperate were also excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: true acupuncture
12 sessions of ACP treatment were performed twice a week.
Before ACP was performed, patients were examined based on the diagnostic pattern of TCM.
Then, the appropriate acupoints for treatment were selected according to the tinnitus-related syndrome.
The experimental group was treated with true ACP (stimulating selected meridian points), and the control group was treated with sham-ACP (stimulating false meridian points).
The patients were blinded to the identity of their treatment group.
Disposable stainless steel ACP needles (0.25 x 30 mm, Dong Bang Acupuncture, Korea) were used in both groups.
Needles were inserted manually at each meridian point, and the retention time was twenty minutes.
|
All treatments were performed by the same acupuncturist, who is a medical doctor with more than eight years of clinical and research experience in ACP for tinnitus.
Acupoints described as being effective for tinnitus were selected according to TCM theory.
Basic points that are manipulated in ACP include GV 20 (Baihui), TE 17 (Yifeng), GB 8 (Shuaigu), SI 19 (Tinggong), GB 2 (Tinghui), TE 21 (Ermen), VC 23 (Lianquan), GB 20 (Fengchi), TE 2 (Yemen), TE 5 (Waiguan), SI 2 (Qiangu), GB 43 (Xiaxi) and GB 41 (Zulinqi).
However, several secondary (accessory) acupoints were also added according to TCM and the etiological diagnosis of tinnitus: GV 4 (Mingmen), KI 3 (Taixi), BL 23 (Shenshu), BL 19 (Danshu), BL 18 (Ganshu) and CV 4 (Guanyuan).
|
Sham Comparator: sham acupuncture
The control group was treated with sham-ACP (stimulating false meridian points).
Disposable stainless steel ACP needles (0.25 x 30 mm, Dong Bang Acupuncture, Korea) were used.
Needles were inserted manually at each false meridian point, and the retention time was twenty minutes.
|
All treatments were performed by the same acupuncturist, who is a medical doctor with more than eight years of clinical and research experience in ACP for tinnitus.
Acupoints described as being effective for tinnitus were selected according to TCM theory.
Basic points that are manipulated in ACP include GV 20 (Baihui), TE 17 (Yifeng), GB 8 (Shuaigu), SI 19 (Tinggong), GB 2 (Tinghui), TE 21 (Ermen), VC 23 (Lianquan), GB 20 (Fengchi), TE 2 (Yemen), TE 5 (Waiguan), SI 2 (Qiangu), GB 43 (Xiaxi) and GB 41 (Zulinqi).
However, several secondary (accessory) acupoints were also added according to TCM and the etiological diagnosis of tinnitus: GV 4 (Mingmen), KI 3 (Taixi), BL 23 (Shenshu), BL 19 (Danshu), BL 18 (Ganshu) and CV 4 (Guanyuan).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Ethylcysteinate dimer single-photon emission computer tomography (99mTc-ECD SPECT)
Time Frame: SPECT exam was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
SPECT exam was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Tinnitus Handicap Inventory (THI)
Time Frame: The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
Visual Analog Scale (VAS)
Time Frame: The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
Hamilton Anxiety Scale (HAS)
Time Frame: The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
Beck Depression Inventory (BDI)
Time Frame: The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
The scale was performed seven days before (baseline) and seven days after acupuncture treatment (up to six weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Andrea P Jackowski, PhD, Federal University of São Paulo UNIFESP
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
October 28, 2014
First Submitted That Met QC Criteria
November 8, 2014
First Posted (Estimate)
November 13, 2014
Study Record Updates
Last Update Posted (Estimate)
November 13, 2014
Last Update Submitted That Met QC Criteria
November 8, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FAPESP-2010/14804-6
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tinnitus
-
State University of New York at BuffaloUniversity at BuffaloCompletedTinnitus, Subjective | Tinnitus | Noise Induced Tinnitus | Tinnitus, Objective | Tinnitus Aggravated | Tinnitus, Pulsatile | Tinnitus, Spontaneous Oto-Acoustic Emission | Tinnitus, Clicking | Tinnitus, Tensor Tympani InducedUnited States
-
Mohab MohammedNot yet recruitingPulsatile Tinnitus (Diagnosis)
-
Philipps University Marburg Medical CenterLinkoeping University; Eriksholm Research Centre; University Hospital of Gießen...CompletedTinnitus | Subjective Tinnitus | Chronic TinnitusGermany
-
University of GuadalajaraHospital Civil de Guadalajara; Institute of Experimental and Clinical TherapeuticsRecruitingOxidative Stress | Tinnitus, Subjective | Tinnitus, Bilateral | Antioxidant Therapy | Psychiatric Drugs | Inflammatory Cytokines | SSRIMexico
-
University Hospital, BordeauxNot yet recruiting
-
Cairo UniversityRecruiting
-
University of ZurichRecruitingTinnitus, Subjective | TinnitusSwitzerland
-
Eye & ENT Hospital of Fudan UniversityNot yet recruiting
-
University of Illinois at Urbana-ChampaignGN Hearing A/SActive, not recruitingTinnitus, SubjectiveUnited States
-
University of ZurichCompletedTinnitus, SubjectiveGermany, Switzerland
Clinical Trials on Acupuncture
-
Federal University of São PauloCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown
-
Chengdu University of Traditional Chinese MedicineChongqing Medical University; Hunan University of Traditional Chinese MedicineCompletedFunctional Dyspepsia | Postprandial Distress SyndromeChina
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
University Medicine GreifswaldRecruitingGagging During Transesophageal EchocardiographyGermany
-
Huazhong University of Science and TechnologyThe University of Hong Kong; Heilongjiang University of Chinese Medicine; Hubei...CompletedPolycystic Ovary SyndromeChina
-
China Medical University HospitalNot yet recruiting